SB 45

  • Kentucky Senate Bill
  • 2021 Regular Session
  • Introduced in Senate Jan 05, 2021
  • Passed Senate Feb 26, 2021
  • Passed House Mar 16, 2021
  • Signed by Governor Mar 25, 2021

AN ACT relating to prescription drugs.

Votes


Actions


Mar 25, 2021

Senate

signed by Governor (Acts Ch. 134)

Mar 16, 2021

Senate

delivered to Governor

House

enrolled, signed by Speaker of the House

Senate

Senate concurred in House Committee Substitute (1)

Senate

enrolled, signed by President of the Senate

Senate

Bill passed 35-0

Mar 15, 2021

Senate

posted for passage for concurrence in House Committee Substitute (1) for Tuesday, March 16, 2021

Mar 12, 2021

Senate

received in Senate

Senate

to Rules (S)

Senate

3rd reading, passed 89-8 with Committee Substitute

Mar 11, 2021

Senate

posted for passage in the Regular Orders of the Day for Friday, March 12, 2021

Mar 04, 2021

Senate

2nd reading, to Rules

Mar 03, 2021

Senate

reported favorably, 1st reading, to Calendar with Committee Substitute

Mar 01, 2021

House

to Committee on Committees (H)

Senate

posted in committee

House

to Banking & Insurance (H)

House

received in House

Feb 26, 2021

Senate

3rd reading, passed 36-0 with Committee Substitute

Feb 25, 2021

Senate

posted for passage in the Consent Orders of the Day for Friday, February 26, 2021

Feb 24, 2021

Senate

2nd reading, to Rules

Feb 23, 2021

Senate

reported favorably, 1st reading, to Consent Calendar with Committee Substitute (1)

Feb 02, 2021

Senate

to Banking & Insurance (S)

Jan 05, 2021

Senate

introduced in Senate

Senate

to Committee on Committees (S)

Dec 09, 2020

Senate

Prefiled by the sponsor(s).

Bill Text

Bill Text Versions Format
Acts Chapter 134 PDF
Current/Final PDF
Introduced PDF

Related Documents

Document Format
Proposed House Committee Substitute 1
Proposed Senate Committee Substitute 1

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.